MSB 4.66% $1.13 mesoblast limited

Ann: FDA Accepts Mesoblast's BLA Resubmission for Remestemcel-L, page-571

  1. 6,753 Posts.
    lightbulb Created with Sketch. 1461
    Couldn’t agree more @wot. Remestemcel-L will be life-giving to the children suffering & life-changing to their families. To think these children have fought cancer & then had to fight again, a David & Goliath battle, for the RIGHT to live.

    To deny this curative treatment would be unconscionable.


 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.13
Change
-0.055(4.66%)
Mkt cap ! $1.284B
Open High Low Value Volume
$1.18 $1.18 $1.13 $4.824M 4.236M

Buyers (Bids)

No. Vol. Price($)
2 25589 $1.13
 

Sellers (Offers)

Price($) Vol. No.
$1.13 10000 1
View Market Depth
Last trade - 16.10pm 17/07/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.